Effect of safranal on the response of cancer cells to topoisomerase I inhibitors: Does sequence matter?
Lama Lozon(University of Sharjah), Raafat El‐Awady(American Association of Colleges of Pharmacy)
Cited by 24
Related Papers
The impact of CBP expression in estrogen receptor-positive breast cancer
|Clinical Epigenetics|2021|37
Design, synthesis and mechanistic anticancer activity of new acetylated 5-aminosalicylate-thiazolinone hybrid derivatives
|iScience|2023|8
Discovery of Novel Class of Histone Deacetylase Inhibitors as Anticancer Agents
|Research Square|2021|0